Pituitary Gland Neoplasm
NCI Definition: A benign or malignant neoplasm affecting the pituitary gland. The vast majority are adenomas arising from the anterior lobe of the pituitary gland. 
Pituitary gland neoplasms most frequently harbor alterations in GNAS, PRKDC, ARID1B, PTPRD, and FANCA .
GNAS Mutation, PRKDC Mutation, ARID1B Mutation, FANCA Mutation, and KMT2D Mutation are the most common alterations in pituitary gland neoplasm .
There is 1 clinical trial for pituitary gland neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains pituitary gland neoplasm as an inclusion criterion, 1 is phase 1 (1 open).
Pritumumab is the most common intervention in pituitary gland neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.